308 related articles for article (PubMed ID: 25257913)
1. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology.
Hayakawa T; Kunihiro T; Ando T; Kobayashi S; Matsui E; Yada H; Kanda Y; Kurokawa J; Furukawa T
J Mol Cell Cardiol; 2014 Dec; 77():178-91. PubMed ID: 25257913
[TBL] [Abstract][Full Text] [Related]
2. Conduction and contraction properties of human iPS cell-derived cardiomyocytes: analysis by motion field imaging compared with the guinea-pig isolated heart model.
Isobe T; Honda M; Komatsu R; Tabo M
J Toxicol Sci; 2018; 43(8):493-506. PubMed ID: 30078835
[TBL] [Abstract][Full Text] [Related]
3. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy.
Pillekamp F; Haustein M; Khalil M; Emmelheinz M; Nazzal R; Adelmann R; Nguemo F; Rubenchyk O; Pfannkuche K; Matzkies M; Reppel M; Bloch W; Brockmeier K; Hescheler J
Stem Cells Dev; 2012 Aug; 21(12):2111-21. PubMed ID: 22268955
[TBL] [Abstract][Full Text] [Related]
4. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effects of power-frequency magnetic fields on the electrical activity of cardiomyocytes differentiated from human induced pluripotent stem cells.
Takahashi M; Saito A; Jimbo Y; Nakasono S
J Toxicol Sci; 2017; 42(2):223-231. PubMed ID: 28321048
[TBL] [Abstract][Full Text] [Related]
6. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
[TBL] [Abstract][Full Text] [Related]
7. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
8. Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation.
Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
Toxicol Sci; 2019 Feb; 167(2):573-580. PubMed ID: 30365015
[TBL] [Abstract][Full Text] [Related]
9. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
Isobe T; Honda M; Komatsu R; Tabo M
J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes.
Watanabe H; Honda Y; Deguchi J; Yamada T; Bando K
J Toxicol Sci; 2017; 42(4):519-527. PubMed ID: 28717111
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
Himmel HM
J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative.
Takasuna K; Asakura K; Araki S; Ando H; Kazusa K; Kitaguchi T; Kunimatsu T; Suzuki S; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 83():42-54. PubMed ID: 27646297
[TBL] [Abstract][Full Text] [Related]
14. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.
Kopljar I; De Bondt A; Vinken P; Teisman A; Damiano B; Goeminne N; Van den Wyngaert I; Gallacher DJ; Lu HR
Br J Pharmacol; 2017 Nov; 174(21):3766-3779. PubMed ID: 28094846
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
Feaster TK; Casciola M; Narkar A; Blinova K
Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the Direction and Order of the Motion Unveiled the Ability of Conventional Monolayers of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Show Frequency-Dependent Enhancement of Contraction and Relaxation Motion.
Izumi-Nakaseko H; Chiba K; Hagiwara-Nagasawa M; Satsuka A; Goto A; Nunoi Y; Kambayashi R; Matsumoto A; Takei Y; Kanda Y; Naito AT; Sugiyama A
Front Cell Dev Biol; 2020; 8():542562. PubMed ID: 33015053
[TBL] [Abstract][Full Text] [Related]
17. Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro.
Shinozawa T; Imahashi K; Sawada H; Furukawa H; Takami K
J Biomol Screen; 2012 Oct; 17(9):1192-203. PubMed ID: 22706346
[TBL] [Abstract][Full Text] [Related]
18. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
19. Human induced pluripotent stem cell-derived fiber-shaped cardiac tissue on a chip.
Morimoto Y; Mori S; Sakai F; Takeuchi S
Lab Chip; 2016 Jun; 16(12):2295-301. PubMed ID: 27217209
[TBL] [Abstract][Full Text] [Related]
20. A mathematical model of hiPSC cardiomyocytes electromechanics.
Forouzandehmehr M; Koivumäki JT; Hyttinen J; Paci M
Physiol Rep; 2021 Nov; 9(22):e15124. PubMed ID: 34825519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
